盐酸尼罗替尼一水合物，CAS 登记号 923288-90-8，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 盐酸尼罗替尼一水合物 的 CAS 号：923288-90-8，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
Nilotinib hcl monohydrate · CAS 923288-90-8 · C28H25ClF3N7O2. UNII 5JHU0N1R6K. European Pharmacopoeia monograph.
| CAS Registry Number | 923288-90-8 |
|---|---|
| PubChem CID | 16757572 |
| Molecular formula | C28H25ClF3N7O2 |
| IUPAC name | 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide;hydrate;hydrochloride |
| UNII (FDA) | 5JHU0N1R6K |
| Pharmacopoeial monograph | European Pharmacopoeia monograph |
| Molecular Weight | 584.0 |
|---|---|
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 6 |
| Exact Mass | 583.1710352 |
| Monoisotopic Mass | 583.1710352 |
| Topological Polar Surface Area | 98.6 |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 817 |
| Reported hazard statements | H302 (75%), H317 (75%), H410 (16.7%) |
|---|
H302 (75%): Harmful if swallowed [Warning Acute toxicity, oral]
H317 (75%): May cause an allergic skin reaction [Warning Sensitization, Skin]
923288-90-8; Nilotinib hydrochloride monohydrate; Nilotinib monohydrochloride monohydrate; Nilotinib hydrochloride hydrate; 5JHU0N1R6K; Nilotinib hydrochloride hydrate [JAN]; Nilotinib hydrochloride monohydrate [Orange Book]; DTXSID00238967; Nilotinib hydrochloride hydrate (JAN); NILOTINIB HYDROCHLORIDE MONOHYDRATE [MI]; NILOTINIB HYDROCHLORIDE MONOHYDRATE [EP MONOGRAPH]; NILOTINIB HYDROCHLORIDE MONOHYDRATE (EP MONOGRAPH); RefChem:854151; DTXCID50161458; 641571-10-0, Nilotinib; Nilotinib HCl monohydrate
CAS 923288-90-8; molecular formula C28H25ClF3N7O2; molecular weight — g/mol.
923288-90-8, Nilotinib hydrochloride monohydrate, Nilotinib monohydrochloride monohydrate, Nilotinib hydrochloride hydrate, 5JHU0N1R6K, Nilotinib hydrochloride hydrate [JAN].
Hazard statements reported: H302, H317, H410.
Yes — a monograph exists in the European Pharmacopoeia (Ph. Eur.).
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.